Mission

« …, a person living to age 40 years has a one in five risk of developing heart failure and, once the disorder is apparent, a one in three chance of dying within a year of diagnosis. » McMurray and Pfeffer, Lancet, 2005, 365:1877-1889.

Cardio3 BioSciences aims to discover, develop and commercialize regenerative and protective therapies for cardiovascular diseases.